Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

SA Transcripts159.13K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call March 26, 2026 4:30 PM EDT Company Participants Talat Imran - CEO & DirectorSvai Sanford - Chief Financial Officer Conference Call Participants Stephen JasperBrandon Folkes - H.C. Wainwright & Co, LLC, Research DivisionMichael Okunewitch - Maxim Group LLC, Research Division Presentation Operator Welcome to the Rani Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, March 26, 2026. I would now like to turn the conference over to your speaker for today, Stephen Jasper of Gilmartin Group. Please go ahead.

Stephen Jasper Thank you, operator. Joining us on the call today from Rani Therapeutics are Chief Executive Officer, Talat Imran; and Chief Financial Officer, Svai Sanford. Earlier today, Rani released financial results for the quarter and year ended December 31, 2025. A copy of the press release is available on the company's website. During this conference call, management will make forward-looking statements that are subject to risks, uncertainties and assumptions such as, but not limited to, those discussed in the Risk Factors section of the company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K filed today, which identify the specific factors that may cause actual results or events to differ materially from those described in these forward-looking statements. These statements may include, without limitation, statements regarding product development and clinical trials, product potential, market sizes, platform progress, platform potential, certain business strategies, strategic partnership with Chugai, including potential milestone payments under the Chugai license and collaboration agreement, capital resources, projected cash runway, financing plans or operating performance. Actual results and the timing of events could differ materially from those projected in such forward-looking statements. With that, I will